Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic Boolean modeling of molecular and cellular interactions in psoriasis predicts drug target candidates. | iScience | 2024 | 38303723 | PubTator, text mining | PubMed |
| Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. | Genes Dis | 2024 | 38292177 | PubTator, text mining | PubMed |
| Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years. | Int J Dermatol | 2024 | 38284277 | PubTator, text mining | PubMed |
| Proteome Analysis of Serum Purified Using Solanum tuberosum and Lycopersicon esculentum Lectins. | Int J Mol Sci | 2024 | 38279312 | PubTator, text mining | PubMed |
| The Role of the CD28 Family Receptors in T-Cell Immunomodulation. | Int J Mol Sci | 2024 | 38279272 | PubTator, text mining | PubMed |
| Traversing through the Mechanistic Event Analysis in IL-6 and IL-17 Signaling for a New Therapeutic Paradigm in NSCLC. | Int J Mol Sci | 2024 | 38279220 | PubTator, text mining | PubMed |
| HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation. | Pathogens | 2024 | 38276160 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms. | Viruses | 2024 | 38275971 | PubTator, text mining | PubMed |
| Development and validation of an immunogenic cell death-related prognostic model, and landscape of the tumor immune microenvironment in glioblastoma. | Genes Dis | 2024 | 38274376 | PubTator, text mining | PubMed |
| Cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent tumor recurrence. | Acta Pharm Sin B | 2024 | 38261838 | PubTator, text mining | PubMed |
| Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. | Int J Mol Sci | 2024 | 38256115 | PubTator, text mining | PubMed |
| Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro. | Int J Mol Sci | 2024 | 38255960 | PubTator, text mining | PubMed |
| Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets. | Int J Mol Sci | 2024 | 38255845 | PubTator, text mining | PubMed |
| Potential Regulatory Gene Network Associated with the Ameliorative Effect of Oat Antibacterial Peptides on Rat Colitis. | Foods | 2024 | 38254536 | PubTator, text mining | PubMed |
| Umbilical Cord Mesenchymal Stromal/Stem Cells and Their Interplay with Th-17 Cell Response Pathway. | Cells | 2024 | 38247860 | PubTator, text mining | PubMed |
| Lung Epithelial Regnase-1 Dampens Local Immune Response but Does Not Worsen Susceptibility to Klebsiella pneumoniae. | Immunohorizons | 2024 | 38226923 | PubTator, text mining | PubMed |
| Exosomal microRNA-Based therapies for skin diseases. | Regen Ther | 2024 | 38178928 | PubTator, text mining | PubMed |
| Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. | Nat Commun | 2024 | 38172124 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic Potential. | J Cancer | 2024 | 38169510 | PubTator, text mining | PubMed |
| Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis. | Arthritis Res Ther | 2024 | 38167328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=14